Esomeprazole 2.5mg DR Pwdr Pkt Susp

Manufacturer CIPLA USA Active Ingredient Esomeprazole Powder for Suspension(es oh ME pray zol) Pronunciation es oh ME pray zol
It is used to treat gastroesophageal reflux disease (GERD; acid reflux).It is used to treat heartburn.It is used to treat or prevent GI (gastrointestinal) ulcers caused by infection.It is used to treat or prevent ulcers of the esophagus.It is used to treat syndromes caused by lots of stomach acid.It is used to treat or prevent nonsteroidal anti-inflammatory drugs (NSAID)- associated gastric ulcers in patients with a history of ulcers. Examples of NSAIDs include ibuprofen and naproxen.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antiulcer agent
đŸ§Ŧ
Pharmacologic Class
Proton pump inhibitor (PPI)
🤰
Pregnancy Category
Category B
✅
FDA Approved
Feb 2001
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Esomeprazole is a medicine that reduces the amount of acid your stomach makes. It's used to treat conditions like heartburn, acid reflux (GERD), and stomach ulcers. It works by blocking tiny pumps in your stomach that produce acid.
📋

How to Use This Medicine

Taking Your Medication Correctly

To ensure you get the most out of your medication, follow these steps carefully:

1. Follow Your Doctor's Orders: Take this medication exactly as directed by your doctor. Read all the information provided to you and follow the instructions closely.
2. Timing and Preparation: Take your dose 1 hour before a meal. To prepare, mix the contents of the packet with water as follows:
For 2.5 mg or 5 mg packets, use 1 teaspoon (5 mL) of water.
For 10 mg, 20 mg, or 40 mg packets, use 1 tablespoon (15 mL) of water.
* If you need to take 2 packets, double the amount of water.
3. Mixing and Waiting: Stir the packet contents into the water, then let it sit for 2 to 3 minutes. After waiting, mix well and drink the entire dose within 30 minutes.
4. Disposal and Cleaning: Throw away any unused portion of the medication within 30 minutes of mixing. Rinse your cup with more water and drink to ensure you get the full dose.
5. Continuing Your Medication: Keep taking this medication as directed by your doctor or healthcare provider, even if you start to feel well.

Special Instructions for Feeding Tubes

If you have a feeding tube, your medication can still be given to you. Follow these steps:

1. Preparing the Medication: For 2.5 mg or 5 mg packets, add 5 mL of water to a syringe, then add the packet contents. For 10 mg, 20 mg, or 40 mg packets, add 15 mL of water to a syringe, then add the packet contents.
2. Mixing and Administering: Replace the plunger and shake the syringe. Let it sit for 2 to 3 minutes, then shake again and give the medication through the feeding tube.
3. Flushing the Tube: After giving the medication, refill the syringe with the same amount of water used, shake, and flush the feeding tube.

Storing and Disposing of Your Medication

To keep your medication safe and effective:

1. Storage: Store your medication at room temperature in a dry place, away from bathrooms.
2. Keeping it Safe: Keep all medications in a safe place, out of the reach of children and pets.
3. Disposal: Throw away unused or expired medications. Do not flush them down the toilet or pour them down the drain unless instructed to do so. Check with your pharmacist for the best way to dispose of your medication, and consider participating in drug take-back programs in your area.

What to Do if You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and go back to your normal schedule. Do not take two doses at the same time or extra doses.
💡

Lifestyle & Tips

  • Take this medicine at least 1 hour before your first meal of the day.
  • Do not crush or chew the granules in the packet. Mix the powder with water as directed and swallow immediately.
  • Avoid foods and drinks that trigger your acid reflux (e.g., spicy foods, fatty foods, caffeine, alcohol, citrus, chocolate).
  • Eat smaller, more frequent meals.
  • Avoid lying down for at least 3 hours after eating.
  • Elevate the head of your bed if you experience nighttime reflux.
  • Maintain a healthy weight.
  • Quit smoking.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 20 mg or 40 mg once daily, 30-60 minutes before a meal
Dose Range: 20 - 40 mg

Condition-Specific Dosing:

GERD with Erosive Esophagitis: 20 mg or 40 mg once daily for 4-8 weeks; maintenance 20 mg once daily
Symptomatic GERD (without erosions): 20 mg once daily for 4 weeks
Risk Reduction of NSAID-Associated Gastric Ulcers: 20 mg once daily for up to 6 months
H. pylori Eradication (in combination therapy): 40 mg once daily for 10 days (with amoxicillin and clarithromycin)
Zollinger-Ellison Syndrome: Initial 40 mg twice daily; adjust to patient needs, up to 240 mg/day
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established for 2.5mg packet. For GERD in infants 1 month to <1 year: 2.5 mg or 5 mg once daily (based on weight).
Child: GERD with Erosive Esophagitis (1-11 years, <20 kg): 10 mg once daily for 8 weeks. (1-11 years, >=20 kg): 10 mg or 20 mg once daily for 8 weeks. (12-17 years): 20 mg or 40 mg once daily for 4-8 weeks.
Adolescent: GERD with Erosive Esophagitis (12-17 years): 20 mg or 40 mg once daily for 4-8 weeks. Symptomatic GERD (12-17 years): 20 mg once daily for 4 weeks.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed
Dialysis: No adjustment needed; Esomeprazole is not significantly removed by hemodialysis.

Hepatic Impairment:

Mild: No adjustment needed (Child-Pugh A)
Moderate: No adjustment needed (Child-Pugh B)
Severe: Consider dose reduction to 20 mg once daily for erosive esophagitis (Child-Pugh C). No more than 20 mg/day for other indications.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Esomeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase (proton pump) in the gastric parietal cell. It is the S-isomer of omeprazole. By acting specifically on the proton pump, esomeprazole blocks the final step in acid production, thus reducing gastric acidity regardless of the stimulus.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 64% (single dose), increasing to 89% with repeated once-daily dosing (due to reduced first-pass metabolism)
Tmax: 1.5 hours
FoodEffect: Food delays and decreases the absorption of esomeprazole, but this does not significantly affect its efficacy. Administer at least 1 hour before a meal.

Distribution:

Vd: 0.22-0.35 L/kg
ProteinBinding: Approximately 97%
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 1-1.5 hours (plasma elimination half-life)
Clearance: Not available (highly variable due to first-pass metabolism)
ExcretionRoute: Mainly urine (80%) and feces (20%) as metabolites
Unchanged: <1% in urine
âąī¸

Pharmacodynamics

OnsetOfAction: Within 1 hour
PeakEffect: Within 2-4 days of daily dosing (for maximal acid suppression)
DurationOfAction: Up to 24 hours (due to irreversible binding to the proton pump)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain, cramps, or spasms
+ Weakness
+ Shakiness
+ Changes in balance
+ Abnormal heartbeat
+ Seizures
+ Loss of appetite
+ Severe nausea or vomiting
Signs of kidney problems, such as:
+ Inability to urinate
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Severe dizziness or fainting
Bone pain
Significant weight loss
Symptoms of C. difficile-associated diarrhea (CDAD), including:
+ Stomach pain or cramps
+ Very loose or watery stools
+ Bloody stools
+ Do not attempt to treat diarrhea without consulting your doctor
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions, which can affect body organs and be life-threatening
+ Seek medical help immediately if you experience:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in your mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Headache
Stomach pain or diarrhea
Constipation
Gas
Dry mouth
Upset stomach

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe stomach pain or diarrhea that doesn't go away
  • New or unusual bone pain or fractures
  • Muscle spasms, tremors, or irregular heartbeat (signs of low magnesium)
  • Unexplained weight loss
  • Difficulty or pain when swallowing
  • Black, tarry stools or vomit that looks like coffee grounds (signs of bleeding)
  • New or worsening rash, especially on sun-exposed areas
  • Signs of kidney problems (e.g., changes in urination, swelling in ankles/feet)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently taking any of the following medications: Atazanavir, Clopidogrel, Methotrexate, Nelfinavir, Rifampin, Rilpivirine, St. John's Wort, or Warfarin.
* If you have a history of any of the following health issues:
+ Black or bloody stools
+ Heartburn accompanied by lightheadedness, sweating, dizziness, or wheezing
+ Chest pain
+ Shoulder pain with shortness of breath
+ Pain that radiates to the arms, neck, or shoulders
+ Lightheadedness
+ Excessive sweating
+ Vomiting blood
+ Difficulty or pain when swallowing food

Please note that this list is not exhaustive, and it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. This will help ensure your safety while taking this medication. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Adhere to the prescribed duration of treatment, as taking this drug for longer than recommended by your doctor may have adverse effects. Additionally, this medication may interfere with certain laboratory tests, so be sure to notify all your healthcare providers and lab personnel that you are taking this drug.

Patients with weak bones (osteoporosis) should be aware that this medication may increase the risk of fractures in the hip, spine, and wrist. This risk may be higher if you take the drug in high doses, for more than a year, or if you are over 50 years old. If you have risk factors for osteoporosis, such as a history of alcohol consumption, smoking, steroid use, seizure medication, or a family history of osteoporosis, exercise caution and discuss your risks with your doctor.

Prolonged use of this medication (typically more than 3 months) may lead to rare but potentially serious side effects, including low magnesium levels. Most cases occur after at least 1 year of treatment, and low magnesium levels can cause other electrolyte problems. Your doctor may recommend regular blood tests to monitor your condition.

Long-term treatment with this medication (usually more than 3 years) has been associated with rare cases of low vitamin B-12 levels. Be aware of the symptoms of low vitamin B-12 levels, which may include shortness of breath, dizziness, abnormal heartbeat, muscle weakness, pale skin, tiredness, mood changes, or numbness or tingling in the arms or legs. If you experience any of these symptoms, contact your doctor immediately.

In rare cases, this medication has been linked to the development or worsening of lupus. If you have a history of lupus, inform your doctor, and seek medical attention immediately if you experience symptoms such as a rash on the cheeks or other body parts, changes in skin color, easy sunburn, muscle or joint pain, chest pain or shortness of breath, or swelling in the arms or legs.

Taking this medication for more than 1 year may increase the risk of developing stomach growths called fundic gland polyps. If you have concerns, discuss them with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks of this medication to you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Confusion
  • Blurred vision
  • Tachycardia (fast heart rate)
  • Nausea
  • Sweating
  • Flushing
  • Headache
  • Dry mouth

What to Do:

Seek immediate medical attention or call a poison control center. In the US, call 1-800-222-1222. Treatment is generally supportive and symptomatic.

Drug Interactions

🔴

Major Interactions

  • Clopidogrel (decreased antiplatelet effect)
  • Nelfinavir, Atazanavir (decreased antiviral effect)
  • Rilpivirine (decreased antiviral effect)
  • Dasatinib, Erlotinib, Pazopanib, Sunitinib (decreased absorption of tyrosine kinase inhibitors)
  • Methotrexate (increased methotrexate levels, potential toxicity)
🟡

Moderate Interactions

  • Warfarin (increased INR/bleeding risk)
  • Diazepam (decreased clearance of diazepam)
  • Citalopram (increased citalopram exposure)
  • Digoxin (increased digoxin absorption)
  • Tacrolimus (increased tacrolimus levels)
  • Iron salts (decreased iron absorption)
  • Ketoconazole, Itraconazole, Posaconazole (decreased antifungal absorption)
  • Mycophenolate mofetil (decreased mycophenolic acid exposure)
  • St. John's Wort (decreased esomeprazole exposure)
  • Rifampin (decreased esomeprazole exposure)
đŸŸĸ

Minor Interactions

  • Sucralfate (decreased esomeprazole absorption if given concurrently)
  • Food (delays absorption, but not clinically significant for efficacy)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Baseline symptoms of GERD/acid-related conditions

Rationale: To assess initial severity and guide treatment

Timing: Prior to initiation of therapy

Magnesium levels

Rationale: To establish baseline, especially in patients at risk for hypomagnesemia (e.g., concomitant diuretics, other drugs causing hypomagnesemia)

Timing: Prior to initiation of long-term therapy (>=3 months)

📊

Routine Monitoring

Symptom resolution/control

Frequency: Periodically, as clinically indicated (e.g., at follow-up visits)

Target: Significant reduction or absence of symptoms

Action Threshold: Persistent or worsening symptoms may indicate need for dose adjustment, alternative therapy, or further diagnostic workup.

Magnesium levels

Frequency: Periodically (e.g., every 3-6 months) for patients on long-term therapy (>=3 months) or with risk factors

Target: Normal serum magnesium levels (1.7-2.2 mg/dL)

Action Threshold: Levels below normal range; consider supplementation or discontinuation of PPI if severe and persistent.

Bone mineral density (BMD)

Frequency: Consider for patients at high risk for osteoporosis on long-term therapy (>1 year)

Target: Maintain healthy BMD

Action Threshold: Significant decline in BMD; consider calcium/vitamin D supplementation or alternative therapy.

Vitamin B12 levels

Frequency: Consider for patients on very long-term therapy (>3 years) or with risk factors for B12 deficiency

Target: Normal serum B12 levels

Action Threshold: Levels below normal range; consider supplementation.

đŸ‘ī¸

Symptom Monitoring

  • Persistent or worsening heartburn
  • Dysphagia (difficulty swallowing)
  • Odynophagia (painful swallowing)
  • Unexplained weight loss
  • Recurrent vomiting
  • Gastrointestinal bleeding (black, tarry stools; coffee-ground emesis)
  • New or worsening diarrhea (especially watery or bloody)
  • Muscle cramps, weakness, tremors, or arrhythmias (signs of hypomagnesemia)
  • Fatigue, pallor, numbness/tingling (signs of B12 deficiency)

Special Patient Groups

🤰

Pregnancy

Esomeprazole is generally considered low risk during pregnancy (Pregnancy Category B). Studies in animals have not shown harm, and human data suggest no increased risk of major birth defects. Use only if clearly needed.

Trimester-Specific Risks:

First Trimester: Low risk, but use only if benefits outweigh potential risks.
Second Trimester: Generally considered safe.
Third Trimester: Generally considered safe.
🤱

Lactation

Esomeprazole is excreted into breast milk in small amounts (Lactation Risk L2 - Safer). The amount is generally considered too low to cause adverse effects in breastfed infants. Monitor infant for any signs of adverse effects (e.g., diarrhea, rash).

Infant Risk: Low risk of adverse effects.
đŸ‘ļ

Pediatric Use

Approved for use in pediatric patients 1 month to 17 years for certain indications (GERD, erosive esophagitis). Dosing is weight-based for younger children. Safety and efficacy in infants younger than 1 month have not been established.

👴

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. No dosage adjustment is generally needed based solely on age. However, elderly patients may be more susceptible to long-term adverse effects such as bone fractures and hypomagnesemia.

Clinical Information

💎

Clinical Pearls

  • Esomeprazole is the S-isomer of omeprazole, often marketed as a 'next-generation' PPI due to potentially more consistent pharmacokinetics.
  • Administer 30-60 minutes before the first meal of the day to maximize efficacy, as the proton pumps are most active after a period of fasting.
  • For patients unable to swallow capsules, the delayed-release powder for oral suspension is a suitable alternative.
  • Long-term PPI use (especially >1 year) has been associated with increased risks of bone fractures (hip, wrist, spine), C. difficile infection, hypomagnesemia, and vitamin B12 deficiency. Periodically assess the need for continued therapy.
  • PPIs can mask symptoms of gastric malignancy; consider endoscopy in patients with persistent symptoms despite therapy, or with alarm symptoms (e.g., weight loss, dysphagia, GI bleeding).
  • Avoid concomitant use with clopidogrel due to potential reduction in clopidogrel's antiplatelet effect via CYP2C19 inhibition. Consider alternative antiplatelet therapy or alternative acid suppression if necessary.
🔄

Alternative Therapies

  • Other Proton Pump Inhibitors (PPIs): Omeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Dexlansoprazole
  • H2-receptor antagonists (H2RAs): Famotidine, Ranitidine (withdrawn in some regions), Cimetidine, Nizatidine
  • Antacids (e.g., calcium carbonate, aluminum hydroxide/magnesium hydroxide)
  • Sucralfate (for ulcer treatment)
  • Prokinetics (e.g., Metoclopramide, for motility disorders)
💰

Cost & Coverage

Average Cost: Highly variable, typically $10-$100+ per 30 packets
Generic Available: Yes
Insurance Coverage: Generally Tier 1 or Tier 2 for generic; Tier 3 or higher for brand-name, or may require prior authorization.
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the quantity, and the time it occurred.